Pharos iBio Co.

About:

Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.

Top Investors: Korea Investment Partners, Mirae Asset Venture Investment, DSC Investment, Company K Partners, KDB Capital

Description:

Total Funding Amount:

34B KRW

Headquarters Location:

Anyang, Kyonggi-do, South Korea

Founded Date:

2016-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-06-24

IPO Status:

Private

Industries: